NeurosciencebioRxivPreprint
KCa3.1 Contributes to Neuroinflammation and Nigral Dopaminergic Neurodegeneration in Experimental models of Parkinson's Disease
Manikandan Samidurai, Karthick Chennakesavan, Souvarish Sarkar…·Arthi Kanthasamy
This study shows that inhibiting KCa3.1 channels reduces neuroinflammation and dopaminergic neurodegeneration in Parkinson's disease models.
1 citation